
Meso Foundation Congratulates Dr. Krug on his New Position
The Mesothelioma Applied Research Foundation would like to congratulate Dr. Lee M. Krug on his new position with Bristol-Myers Squibb (BMS), which he will be starting
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
The Mesothelioma Applied Research Foundation would like to congratulate Dr. Lee M. Krug on his new position with Bristol-Myers Squibb (BMS), which he will be starting
Aduro BioTech is conducting a clinical trial to test an investigational new immunotherapy for malignant pleural mesothelioma (MPM). This therapy, called CRS-207, is given to
Alissa Bahr, a student at the University of Notre Dame, is this year’s recipient of special funding provided by the Meso Foundation and the International
On Thursday, May 14, the Meso Foundation interviewed Dr. Charles Simone and Dr. Evan Alley of the University of Pennsylvania Medicine during the Meet the
Lotte has done it all! She has stuffed envelopes, hand-written thank you notes, peeled hundreds (!) of potatoes, washed as many dishes, cared for mesothelioma
In 2013, we published a blog post for Memorial Day. This year, we want to take a look back at this post, as it remains
A Phase 3 French study, which will be presented at the American Society of Clinical Oncology (ASCO)’s annual meeting at the end of May, demonstrated
by Melinda Kotzian, Chief Executive Officer, Mesothelioma Applied Research Foundation Over the last 24 hours, news broke that some cancer charities raised funds and did
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!